{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:04:37Z","timestamp":1794330277971,"version":"4.9.0"},"reference-count":39,"publisher":"The Endocrine Society","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Patients with congenital adrenal hyperplasia (CAH) are exposed to hyperandrogenism and supraphysiologic glucocorticoids, both of which can increase risk of metabolic morbidity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Our aim was to evaluate cardiovascular and metabolic morbidity risk in a longitudinal study of patients with CAH spanning both childhood and adulthood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design and Setting<\/jats:title>\n                    <jats:p>Patients with classic CAH followed for a minimum of 5 years during both childhood and adulthood (n\u2005=\u200557) at the National Institutes of Health were included and compared with the US general population using NHANES data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Obesity, hypertension, insulin resistance, fasting hyperglycemia, and dyslipidemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared to the US population, patients with CAH had higher (P\u2005&amp;lt;\u20050.001) prevalence of obesity, hypertension, insulin resistance, fasting hyperglycemia, and low high-density lipoprotein (HDL) during childhood and obesity (P\u2005=\u20050.024), hypertension (P&amp;lt;0.001), and insulin resistance (P\u2005&amp;lt;\u20050.001) during adulthood. In our cohort, obesity, hypertension, fasting hyperglycemia, and hypertriglyceridemia began prior to age 10. During childhood, increased mineralocorticoid dose was associated with hypertension (P\u2005=\u20050.0015) and low HDL (P\u2005=\u20050.0021). During adulthood, suppressed androstenedione was associated with hypertension (P\u2005=\u20050.002), and high low-density lipoprotein (P\u2005=\u20050.0039) whereas suppressed testosterone (P\u2005=\u20050.003) was associated with insulin resistance. Elevated 17-hydroxyprogesterone, possibly reflecting poor disease control, was protective against high cholesterol (P\u2005=\u20050.0049) in children. Children whose mothers were obese (maternal obesity) had increased risk of obesity during adulthood (P\u2005=\u20050.0021). Obesity, in turn, contributed to the development of hypertension, insulin resistance, and hypertriglyceridemia in adulthood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with CAH develop metabolic morbidity at a young age associated with treatment-related and familial factors. Judicious use of glucocorticoid and mineralocorticoid is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgab133","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T04:34:28Z","timestamp":1615091668000},"source":"Crossref","is-referenced-by-count":29,"title":["Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia"],"prefix":"10.1210","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8036-5779","authenticated-orcid":false,"given":"Ahmed","family":"Torky","sequence":"first","affiliation":[{"name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4045-1386","authenticated-orcid":false,"given":"Ninet","family":"Sinaii","sequence":"additional","affiliation":[{"name":"Biostatistics and Clinical Epidemiology Service, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9201-3340","authenticated-orcid":false,"given":"Smita","family":"Jha","sequence":"additional","affiliation":[{"name":"National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Desai","sequence":"additional","affiliation":[{"name":"National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0936-2249","authenticated-orcid":false,"given":"Diala","family":"El-Maouche","sequence":"additional","affiliation":[{"name":"National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD, USA"},{"name":"Division of Endocrinology & Metabolism, George Washington University, Washington, DC,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0637-4559","authenticated-orcid":false,"given":"Ashwini","family":"Mallappa","sequence":"additional","affiliation":[{"name":"National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3746-0460","authenticated-orcid":false,"given":"Deborah P","family":"Merke","sequence":"additional","affiliation":[{"name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA"},{"name":"National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,3,2]]},"reference":[{"issue":"13","key":"2021101913582988300_B1","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMra1909786","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"383","author":"Merke","year":"2020","journal-title":"N Engl J Med"},{"issue":"11","key":"2021101913582988300_B2","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2021101913582988300_B3","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1210\/JC.2015-2093","article-title":"Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish population-based national cohort study","volume":"100","author":"Falhammar","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2021101913582988300_B4","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1210\/jc.2018-01862","article-title":"Cardiovascular and metabolic outcomes in congenital adrenal hyperplasia: a systematic review and meta-analysis","volume":"103","author":"Tamhane","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2021101913582988300_B5","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1210\/jc.2010-0917","article-title":"Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients","volume":"95","author":"Arlt","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2021101913582988300_B6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2265.2009.03587.x","article-title":"Insulin sensitivity and body composition in children with classical and nonclassical congenital adrenal hyperplasia","volume":"72","author":"Williams","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2021101913582988300_B7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/cen.12265","article-title":"Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"80","author":"Subbarayan","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2021101913582988300_B8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00431-017-2875-2","article-title":"Cardio-metabolic risk factors in youth with classical 21-hydroxylase deficiency","volume":"176","author":"Ariyawatkul","year":"2017","journal-title":"Eur J Pediatr"},{"issue":"12","key":"2021101913582988300_B9","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1210\/jc.2012-2102","article-title":"Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia","volume":"97","author":"Finkielstain","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2021101913582988300_B10","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3492","article-title":"Infant BMI or weight-for-length and obesity risk in early childhood","volume":"137","author":"Roy","year":"2016","journal-title":"Pediatrics"},{"issue":"3","key":"2021101913582988300_B11","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"issue":"6","key":"2021101913582988300_B12","first-page":"e13","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"9","key":"2021101913582988300_B13","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"issue":"3","key":"2021101913582988300_B14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jpeds.2007.03.023","article-title":"Insulin resistance in adolescents","volume":"151","author":"Rodden","year":"2007","journal-title":"J Pediatr"},{"issue":"17","key":"2021101913582988300_B15","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"issue":"23","key":"2021101913582988300_B16","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1056\/NEJMoa031049","article-title":"Obesity and the metabolic syndrome in children and adolescents","volume":"350","author":"Weiss","year":"2004","journal-title":"N Engl J Med"},{"issue":"6","key":"2021101913582988300_B17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1006\/pmed.1998.0376","article-title":"Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey","volume":"27","author":"Hickman","year":"1998","journal-title":"Prev Med"},{"key":"2021101913582988300_B18","article-title":"Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.","year":"2002","journal-title":"Circulation"},{"issue":"12","key":"2021101913582988300_B19","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1210\/jc.2006-1069","article-title":"Altered 24-hour blood pressure profiles in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"91","author":"V\u00f6lkl","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2021101913582988300_B20","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s40618-014-0148-8","article-title":"Carotid intima media thickness and other cardiovascular risk factors in children with congenital adrenal hyperplasia","volume":"37","author":"Amr","year":"2014","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2021101913582988300_B21","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1210\/jc.2002-021074","article-title":"Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia","volume":"88","author":"Stikkelbroeck","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2021101913582988300_B22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1365-2265.2011.04309.x","article-title":"Adolescents with congenital adrenal hyperplasia because of 21-hydroxylase deficiency have vascular dysfunction","volume":"76","author":"Harrington","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"13","key":"2021101913582988300_B23","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM199709253371301","article-title":"Predicting obesity in young adulthood from childhood and parental obesity","volume":"337","author":"Whitaker","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"2021101913582988300_B24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000353762","article-title":"Obesity and familial predisposition are significant determining factors of an adverse metabolic profile in young patients with congenital adrenal hyperplasia","volume":"80","author":"Moreira","year":"2013","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"2021101913582988300_B25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2265.2004.02170.x","article-title":"Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome","volume":"62","author":"Diamanti-Kandarakis","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2021101913582988300_B26","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2265.2008.03247.x","article-title":"Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)","volume":"69","author":"Diamanti-Kandarakis","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2021101913582988300_B27","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2021101913582988300_B28","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1038\/s41598-017-02367-y","article-title":"Sex-specific metabolic profiles of androgens and its main binding protein SHBG in a middle aged population without diabetes","volume":"7","author":"Piontek","year":"2017","journal-title":"Sci Rep"},{"key":"2021101913582988300_B29","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fendo.2019.00212","article-title":"Cardiovascular health in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxilase deficiency","volume":"10","author":"Improda","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2021101913582988300_B30","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/ajh\/hpv087","article-title":"Blood pressure in a large cohort of children and adolescents with classic adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency","volume":"29","author":"Bonfig","year":"2016","journal-title":"Am J Hypertens"},{"issue":"8","key":"2021101913582988300_B31","doi-asserted-by":"crossref","first-page":"E1547","DOI":"10.1210\/jc.2014-1486","article-title":"Relationship between final height and health outcomes in adults with congenital adrenal hyperplasia: United Kingdom congenital adrenal hyperplasia adult study executive (CaHASE)","volume":"99","author":"Han","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2021101913582988300_B32","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1210\/jc.2014-1805","article-title":"Cardiovascular abnormalities and impaired exercise performance in adolescents with congenital adrenal hyperplasia","volume":"100","author":"Marra","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2021101913582988300_B33","doi-asserted-by":"crossref","first-page":"E1153","DOI":"10.1210\/jc.2014-4033","article-title":"Increased abdominal adiposity in adolescents and young adults with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"100","author":"Kim","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2021101913582988300_B34","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1530\/EJE-17-0124","article-title":"Mechanisms in endocrinology: the sexually dimorphic role of androgens in human metabolic disease","volume":"177","author":"Schiffer","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2021101913582988300_B35","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2021101913582988300_B36","doi-asserted-by":"crossref","first-page":"M133","DOI":"10.1530\/EJE-15-0354","article-title":"Metabolic comorbidities in Cushing\u2019s syndrome","volume":"173","author":"Ferra\u00f9","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2021101913582988300_B37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/cen.12045","article-title":"Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia","volume":"78","author":"Han","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2021101913582988300_B38","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/cen.12422","article-title":"Cardio-metabolic consequences of glucocorticoid replacement: relevance of ultradian signalling","volume":"80","author":"Henley","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2021101913582988300_B39","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1210\/jc.2016-3989","article-title":"11-oxygenated androgens are biomarkers of adrenal volume and testicular adrenal rest tumors in 21-hydroxylase deficiency","volume":"102","author":"Turcu","year":"2017","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab133\/40744771\/dgab133.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab133\/40744771\/dgab133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T19:22:51Z","timestamp":1634757771000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article\/doi\/10.1210\/clinem\/dgab133\/6156969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,2]]},"references-count":39,"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab133","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,2]]},"article-number":"dgab133"}}